🇺🇸 FDA
Pipeline program

Amchafibrin

FPS-TRA-2017-02

Phase 3 small_molecule completed

Quick answer

Amchafibrin for Osteoarthritis, Knee is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Osteoarthritis, Knee
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials